Xencor, Inc. (XNCR)
24.63
+0.13
(+0.53%)
USD |
NASDAQ |
Oct 09, 16:00
24.59
-0.04
(-0.16%)
After-Hours: 20:00
Xencor Enterprise Value : 1.544B for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.544B |
| October 08, 2026 | 1.535B |
| October 07, 2026 | 1.517B |
| October 06, 2026 | 1.524B |
| October 05, 2026 | 1.619B |
| October 02, 2026 | 1.560B |
| October 01, 2026 | 1.555B |
| September 30, 2026 | 1.568B |
| September 29, 2026 | 1.572B |
| September 28, 2026 | 1.616B |
| September 25, 2026 | 1.483B |
| September 24, 2026 | 1.489B |
| September 23, 2026 | 1.517B |
| September 22, 2026 | 1.584B |
| September 21, 2026 | 1.574B |
| September 18, 2026 | 1.551B |
| September 17, 2026 | 1.541B |
| September 16, 2026 | 1.476B |
| September 15, 2026 | 1.479B |
| September 14, 2026 | 1.537B |
| September 11, 2026 | 1.528B |
| September 10, 2026 | 1.517B |
| September 09, 2026 | 1.567B |
| September 08, 2026 | 1.596B |
| September 04, 2026 | 1.692B |
| Date | Value |
|---|---|
| September 03, 2026 | 1.692B |
| September 02, 2026 | 1.713B |
| September 01, 2026 | 1.788B |
| August 31, 2026 | 1.740B |
| August 28, 2026 | 1.651B |
| August 27, 2026 | 1.860B |
| August 26, 2026 | 1.828B |
| August 25, 2026 | 1.891B |
| August 24, 2026 | 1.869B |
| August 21, 2026 | 1.780B |
| August 20, 2026 | 1.721B |
| August 19, 2026 | 1.759B |
| August 18, 2026 | 1.602B |
| August 17, 2026 | 1.432B |
| August 14, 2026 | 1.448B |
| August 13, 2026 | 1.422B |
| August 12, 2026 | 1.437B |
| August 11, 2026 | 1.356B |
| August 10, 2026 | 1.318B |
| August 07, 2026 | 1.260B |
| August 06, 2026 | 1.200B |
| August 05, 2026 | 1.188B |
| August 04, 2026 | 1.194B |
| August 03, 2026 | 1.156B |
| July 31, 2026 | 1.216B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | 948.96M |
| UroGen Pharma Ltd. | 1.887B |
| MeiraGTx Holdings Plc | 976.23M |
| IDEAYA Biosciences, Inc. | 2.680B |
| Iovance Biotherapeutics, Inc. | 6.371B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.73M |
| Revenue (Quarterly) | 51.22M |
| Total Expenses (Quarterly) | 72.95M |
| EPS Diluted (Quarterly) | -0.2864 |
| Gross Profit Margin (Quarterly) | 95.24% |
| Profit Margin (Quarterly) | -42.42% |
| Earnings Yield | -8.81% |
| Normalized Earnings Yield | -10.69 |